University of Barcelona
Internal medicine, Cirrhosis, Portal hypertension, Portal venous pressure and Surgery are his primary areas of study. His Internal medicine research integrates issues from Gastroenterology, Endocrinology and Cardiology. His research investigates the link between Gastroenterology and topics such as Hepatitis C that cross with problems in Decompensation.
Jaume Bosch combines subjects such as Liver disease, Randomized controlled trial, Pathology and Liver transplantation with his study of Cirrhosis. His study in Portal venous pressure is interdisciplinary in nature, drawing from both Esophageal varices, Varices, Blood pressure and Propranolol. His Surgery research incorporates themes from Radiology and Transjugular intrahepatic portosystemic shunt.
Jaume Bosch mostly deals with Internal medicine, Portal hypertension, Cirrhosis, Portal venous pressure and Endocrinology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Cardiology. His work carried out in the field of Portal hypertension brings together such families of science as Radiology, Liver function, Varices and Surgery.
His Cirrhosis study combines topics in areas such as Liver disease, Hepatitis C, Randomized controlled trial and Ascites. His Portal venous pressure study combines topics from a wide range of disciplines, such as Decompensation, Anesthesia, Propranolol, Blood pressure and Esophageal varices. His Hemodynamics research includes elements of Blood volume and Somatostatin.
His primary scientific interests are in Internal medicine, Cirrhosis, Portal hypertension, Portal venous pressure and Gastroenterology. His study in the fields of Portopulmonary hypertension, Vascular resistance and Clinical trial under the domain of Internal medicine overlaps with other disciplines such as Macitentan and Population. His studies in Portal hypertension integrate themes in fields like Liver function, Ascites and Intensive care medicine.
His research in Portal venous pressure intersects with topics in Decompensation, Cardiology and Surgery. Jaume Bosch focuses mostly in the field of Surgery, narrowing it down to topics relating to Esophageal varices and, in certain cases, Liver disease. His research integrates issues of Portal vein, Prospective cohort study, Venous thrombosis and Beta in his study of Gastroenterology.
His main research concerns Portal venous pressure, Portal hypertension, Internal medicine, Liver disease and Hepatic stellate cell. His Portal venous pressure study contributes to a more complete understanding of Cirrhosis. His specific area of interest is Portal hypertension, where Jaume Bosch studies Transjugular intrahepatic portosystemic shunt.
His work on Portopulmonary hypertension, Vascular resistance and Clinical endpoint as part of general Internal medicine research is frequently linked to Macitentan and Placebo, bridging the gap between disciplines. His Liver disease research is multidisciplinary, incorporating elements of Fibrosis and Liver cell. He has researched Surgery in several fields, including Gastroenterology, Esophageal varices, Hepatitis C and Decompensation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Angiogenesis in liver disease
Mercedes Fernández;David Semela;Jordi Bruix;Isabelle Colle.
Journal of Hepatology (2009)
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation
Jose A. Carrión;Miquel Navasa;Jaume Bosch;Miquel Bruguera.
Liver Transplantation (2006)
Improved Clinical Outcome Using Polytetrafluoroethylene-Coated Stents for TIPS: Results of a Randomized Study
Christophe Bureau;Juan carlos Garcia-Pagan;Philippe Otal;Gilles Pomier-Layrargues.
Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
Marta Casado;Jaume Bosch;Juan Carlos García-Pagán;Conxita Bru.
Prevention of variceal rebleeding.
Jaume Bosch;Juan Carlos García-Pagán.
The Lancet (2003)
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
Mónica Guevara;Pere Ginès;Juan Carlos Bandi;Rosa Gilabert.
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin
Jaume Bosch;David Kravetz;Joan Rodes.
Pathophysiology of portal hypertension.
Jaume Bosch;Pilar Pizcueta;Faust Feu;Mercedes Fernández.
Gastroenterology Clinics of North America (1992)
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
María Gabriela Delgado;Susana Seijo;Ismael Yepes;Ismael Yepes;Linette Achécar.
Clinical Gastroenterology and Hepatology (2012)
Gastric mucosal vascular ectasias causing bleeding in cirrhosis: A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I
Enrique Quintero;Josep M. Pique;Josep A. Bombi;Josep M. Bordas.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: